Posts

Menu Calorie Labels May Exacerbate Eating Disorders, St...

Calorie labeling on restaurant menus has gained traction as a public health meas...

Common Nutrient Deficiencies in Individuals with Type 2...

Micronutrient deficiency, characterized by insufficient levels of essential vita...

UQ Researchers Identify US Variant of Lethal Hendra Virus

Researchers from the University of Queensland have made a groundbreaking discove...

New Urine Test Identifies Aggressive Prostate Cancer

In the realm of prostate cancer screening, traditional methodologies have long r...

Moderate Exercise Helps Curb Appetite, Study Finds

A recent study conducted by researchers at Murdoch University’s Health Futures I...

White Blood Cell Count May Forecast COVID-19 Symptom Se...

CLEVELAND, Ohio (Jan 29, 2025)—Recent scientific advances have transformed the l...

Eisai and Biogen’s Leqembi sBLA set for Alzheimer’s mai...

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosi...

Trying Times for Biopharmaceuticals: How Researchers Ca...

Where can researchers look for a beacon of hope amid trying times in the pharmac...

AI-driven virtual CGM data boosts understanding of T1D ...

This study reinforces the significance of intensive glycaemic control and is a p...

GSK and University of Oxford partner for cancer vaccine...

GSK and the University of Oxford have entered a new research partnership to laun...

Pfizer settles Biohaven kickback claims case for $59.7m

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaur...

MSD wins FDA priority review for Welireg in rare endocr...

If approved, Welireg would be the only available therapy in the US for eligible ...

The AI advantage in discovering new medicines 

With continued investment and growing buzz from the industry, the AI hype is exp...

Tevogen Bio and Microsoft expand AI collaboration to Pr...

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their...

BIA report: UK biotech investment surged to £3.5bn in 2024

The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021...

Ascentage Pharma raises $126m in first biotech IPO of 2025

The funds will support the development of Ascentage’s pipeline, including its le...